Vitiligo and the thyroid: why you should have TSH and antibodies checked

Vitiligo and the thyroid: why you should have TSH and antibodies checked

When a dermatologist says “vitiligo”, most people hear “skin problem”. From an immunological point of view it is more accurately “an autoimmune problem that shows on the skin”. The immune system attacks melanocytes in the same way that, in other autoimmune diseases, it attacks the thyroid, the cells of the pancreas or the hair follicles. That is why these conditions often occur together – and why good vitiligo management includes a blood test, not just a lamp and a cream.

How often vitiligo and the thyroid go together

The link is one of the best documented in dermatology. A meta-analysis of 48 studies with more than 300,000 participants (Vrijman et al., British Journal of Dermatology 2012) found that people with vitiligo have roughly a 2.5-fold higher risk of autoimmune thyroid disease, and thyroid antibodies are found five times more often than in the general population. In practice, 15–20 % of adults with vitiligo have clinically significant thyroid disease, most often Hashimoto’s thyroiditis (autoimmune inflammation leading to an underactive gland), less often Graves’ disease (an overactive gland). In children with vitiligo, antibodies are found in 10–25 % of cases and the risk rises with age.

The association is stronger in non-segmental vitiligo (symmetrical patches on both sides of the body), in women and where autoimmunity runs in the family. In segmental vitiligo (patches in one band on one side of the body) the risk is considerably lower.

Why it happens: shared autoimmune ground

Vitiligo and Hashimoto’s both belong to the diseases in which cytotoxic T cells (CD8+) recognise the body’s own cells as foreign. In vitiligo the target is the melanocyte; in thyroiditis it is the hormone-producing thyroid cell. Genetic studies have found more than 50 risk regions in the DNA linked to vitiligo, and many of them (for example the PTPN22, CTLA4, HLA and TYR genes) overlap with genes for autoimmune thyroid disease, type 1 diabetes, pernicious anaemia and alopecia areata. The trigger is usually a combination of inherited predisposition with oxidative stress, infection, mechanical irritation of the skin (the Koebner phenomenon) or significant psychological stress.

The practical conclusion: vitiligo is often the first visible sign of a broader autoimmune tendency. The thyroid, meanwhile, can “smoulder” for years without symptoms – and finding that out early is far more valuable than waiting for tiredness, weight gain or hair loss.

Which tests to ask for

The British guideline (BAD 2021) and the European task force are clear: everyone with non-segmental vitiligo should have thyroid function checked at diagnosis and then repeatedly, usually once a year, or whenever symptoms appear. The basic panel you can ask your GP or endocrinologist for:

TestWhat it showsNote
TSHthyroid-stimulating hormone – the basic screening testraised TSH = suspected underactive gland, low = suspected overactive
fT4 (free thyroxine)the actual level of thyroid hormonewith TSH, distinguishes subclinical from overt disease
anti-TPOantibodies to thyroid peroxidase – the marker of Hashimoto’s thyroiditiscan be positive years before function is affected
anti-TGantibodies to thyroglobulinsupplementary autoimmunity marker
Vitamin B12, blood glucose, vitamin Dpernicious anaemia, type 1 diabetes, vitamin D deficiencyother common findings alongside vitiligo

Positive antibodies with a normal TSH do not yet mean disease, but they increase the risk that function will decline over time (about 2–4 % a year). In that case a TSH check every 6–12 months is enough. If TSH is raised, the endocrinologist decides on levothyroxine treatment.

Symptoms that should not wait for the yearly check

  • tiredness, sleepiness, feeling cold, weight gain despite an unchanged diet, dry skin, hair loss, constipation, slowed thinking – typical of an underactive thyroid;
  • palpitations, weight loss, sweating, nervousness, hand tremor, insomnia, bulging eyes – typical of an overactive thyroid;
  • a lump or pressure in the neck, difficulty swallowing;
  • in women, irregular periods, difficulty conceiving or repeated miscarriage;
  • new, rapidly appearing vitiligo patches – vitiligo activity and thyroid autoimmunity often go hand in hand.

Does thyroid disease change vitiligo treatment?

Not the phototherapy itself – NB-UVB 311 nm is just as suitable with Hashimoto’s, and taking levothyroxine is no obstacle. Two things do change, though. First, untreated thyroid disease keeps overall autoimmune activity going, and with it the activity of the vitiligo; patients whose thyroid function is corrected often report that the spread of patches slows and the light starts to work better. Second, with marked hypothyroidism the skin is dry and heals more slowly, so the light dose needs to be increased more cautiously.

Supplements commonly used in vitiligo – vitamin D, B12, folic acid, zinc, copper, antioxidants – are fine with thyroid disease. Watch two things only: high doses of iodine (seaweed, kelp) can worsen Hashimoto’s, and selenium has been tested in people with positive anti-TPO at 100–200 µg a day with a modest fall in antibodies – higher doses bring no further benefit. The Vitistop tablets tablets we offer contain copper, zinc, selenium and L-tyrosine within recommended daily amounts; L-tyrosine is a precursor of both thyroid hormones and melanin.

A practical plan for the coming months

  1. Tests: at your next appointment ask for TSH, fT4, anti-TPO and, if possible, B12, vitamin D and blood glucose. Keep the results – with vitiligo it pays to follow the trend.
  2. If a result is positive: endocrinologist; thyroid treatment is usually settled within 2–3 months.
  3. Continue vitiligo treatment in parallel: 311 nm light 2–3 times a week (UVB lamps for home use), gel before each session, daily nutritional support – the routine is set out in our treatment plan.
  4. Photograph the patches once a month in the same light. If the spread stops after the thyroid is corrected, you will see it in the photos before you see it in the mirror.
  5. Check TSH and antibodies once a year, even when you feel well.

If you are unsure how to read the results, or how to fit thyroid treatment around phototherapy, write to us – we advise from our own experience, not instead of your doctor.

Want advice on where to start? Tell us where your patches are and for how long – we reply within one working day with a concrete suggestion.

Write to us UVB lamps 311 nm

Frequently asked questions

Should I have my thyroid checked even if I have no symptoms?

Yes. The vitiligo guidelines recommend testing at diagnosis and then once a year, because Hashimoto’s thyroiditis can be symptom-free for years. The earlier it is found, the simpler it is to treat.

Will vitiligo clear once the thyroid is treated?

Not automatically. Thyroid treatment can slow the spread of patches and improve the response to light, but repigmentation still needs phototherapy or another targeted skin treatment.

Can I take Vitistop tablets with Hashimoto’s?

The composition (copper, zinc, selenium, L-tyrosine, vitamins) is fine with thyroid disease and the doses are within recommended daily amounts. If you take levothyroxine, take supplements at least 4 hours apart from the medicine, because minerals reduce its absorption.

Do children with vitiligo need testing too?

Yes, antibodies are found in 10–25 % of children with vitiligo and the risk rises at puberty. The paediatrician usually checks TSH and anti-TPO at diagnosis and then every year or two.

What other conditions are linked to vitiligo?

Besides the thyroid, mainly pernicious anaemia (B12 deficiency), type 1 diabetes, alopecia areata, Addison’s disease and coeliac disease. All share an autoimmune basis; targeted testing is done according to symptoms.

Read next

Sources: Vrijman C et al. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol 2012; Eleftheriadou V et al. BAD guidelines for the management of people with vitiligo 2021; Spritz RA, Andersen GH. Genetics of vitiligo. Dermatol Clin 2017; DermNet – Vitiligo.

This article is general information and does not replace an examination or advice from a dermatologist or endocrinologist. Our products support skin care alongside the treatment your doctor recommends; results vary from person to person.

Login

Forgotten password

Privacy preferences
We use cookies to enhance your visit of this website, analyze its performance and collect data about its usage. We may use third-party tools and services to do so and collected data may get transmitted to partners in the EU, USA or other countries. By clicking on 'Accept all cookies' you declare your consent with this processing. You may find detailed information or adjust your preferences below.

Privacy declaration

Show details
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The product has been added to your basket
Continue shopping Basket